ELASMOGEN LIMITED
Company number SC467513 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£358,868
Balance sheet as at 2017-01-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-01-15
- Registered office
- Liberty Building, Foresterhill, Aberdeen, AB25 2ZP
- Postcode
- AB25 2ZP
- Capital
- 30 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2025-01-31
- Next due by
- 2026-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-01-15
- Next due by
- 2027-01-29
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 10 resigned
Group structure
Controlled by BGF INVESTMENT MANAGEMENT LIMITED — since 2022-04-29
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA152105 (Tier 1), registered since 2015.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- elasmogen.com
- Phone
- 07077210755
A biopharmaceutical company developing next-generation soloMER™ biologics. Specialising in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Previous company names
| Name | Date changed |
|---|---|
| PACIFIC SHELF 1760 LIMITED | 2014-02-05 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 13 QUEENS ROAD, ABERDEEN, ABERDEENSHIRE, AB15 4YL | 2016-01-29 |
Competitors Aberdeen
This company ranks 17 among research and experimental development on biotechnology in Aberdeen.
The class of 2014
38%
of the 356 companies in this sector incorporated in 2014 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.